HKU Scholars Hub: Browsing DSpace

Browsing by Author Sonneveld, MJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 10 of 10

	Title	Author(s)	Issue Date
	Differential patterns of virological relapse and remission after discontinuation of tenofovir disoproxil fumarate or entecavir: results from a global, multi-ethnic cohort of patients with chronic hepatitis B virus infection (RETRACT-B Study) Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Choi, HSJ Hirode, G Chen, CH Su, T-H Wong, GLH Seto, WKW Hees, SV Papatheodoridi, M Brakenhoff, S Lens, S Sarowar, A Chien, R-N Feld, JJ Forns, X Sonneveld, MJ Papatheodoridis, G Vanwolleghem, T Yuen, RMF Chan, HLY Kao, J-H Hsu, Y-C Cornberg, M Hansen, BE Jeng, WJ Janssen, HLY	2021
	Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B Journal:Clinical Gastroenterology and Hepatology	Choi, HS Hirode, G Chen, CH Su, TH Seto, WKW Ven Hees, S Papatheodoridi, M Lens, S Wong, GL Brakenhoff, SM Chien, RN Feld, JJ Sonneveld, MJ Chan, HL Forns, X Papatheodoridis, GV Vanwolleghem, T Yuen, RMF Hsu, YC Kao, JH Cornberg, M Hansen, BE Jeng, WJ Janssen, HL	2022
	HBsAg loss after nucleo(s)tide analogue withdrawal: relationship with viral antigen levels and hbv genotype Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Sonneveld, MJ Chiu, S-M Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Van Bömmel, F Brakenhoff, S Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Zu Siederdissen, CN Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B CREATE study group,	2021
	HBsAg loss is higher among caucasians compared to Asians after stopping nucleos(t)ide analogue therapy: results from a large, global, multi-ethnic cohort of patients with chronic hepatitis B (RETRACT-B study) Proceeding/Conference:Hepatology	Hirode, G Choi, HSJ Su, TH Wong, GLH Seto, WKW Hees, SV Papatheodoridi, M Brakenhoff, S Lens, S Sarowar, A Chien, RN Forns, X Sonneveld, MJ Papatheodoridis, G Vanwolleghem, T Yuen, RMF Chan, HLY Kao, JH Hsu, YC Chen, CH Hansen, BE Cornberg, M Jeng, WJ Janssen, HLA RETRACT-B Study Group,	2020
	HBV DNA AND HBSAG LEVELS AT 24 WEEKS OFF-TREATMENT PREDICT CLINICAL RELAPSE AND HBSAG LOSS IN HBEAG NEGATIVE PATIENTS WHO DISCONTINUED ANTIVIRAL THERAPY Journal:Gastroenterology	Sonneveld, MJ Chiu, S-M Park, JY Brakenhoff, SM Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M Colombatto, P Van Bömmel, F Janssen, HL Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Brunetto, M Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, C-H Maasoumy, B	26-Sep-2023
	Lower Pre-Treatment HBV DNA Levels Are Associated With Better Off-Treatment Outcomes After Nucleo(S)Tide Analogue Withdrawal In Patients With Chronic Hepatitis B Proceeding/Conference:Hepatology	Sonneveld, MJ Chiu, SM Park, JY Brakenhoff, S Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M Colombatto, P Van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Brunetto, M Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, GV Chen, CH Maasoumy, B	31-Oct-2022
	Nucleos(t)ide analogue withdrawal in chronic hepatitis B patients leads to limited sustained remission in the absence of HBsAg loss: results from the RETRACT-B study. Oral Presentation. Proceeding/Conference:The Liver Meeting 2021 (AASLD 2021), 12-15 November 2021. Hepatology	Hirode, G Hansen, BE Chen, C-H Su, T-H Papatheodoridi, M Lens, S Hees, SV Brakenhoff, S Choi, HSJ Chien, RN Seto, WKW Wong, GLH Feld, JJ Chan, HLY Yuen, RMF Sonneveld, MJ Vanwolleghem, T Forns, X Papatheodoridis, G Kao, J-H Hsu, Y-C Cornberg, M Cornberg, W-J Janssen, HLA RETRACT-B Study Group,	2021
	Prediction of sustained response after nucleo(s)tide analogue cessation using HBsAg and HBcrAg levels – a multicenter study (CREATE) Proceeding/Conference:Hepatology	Sonneveld, MJ Park, JY Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M Van Bömmel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erier, NS Höner zu SiederdissenC, C Wedemeyer, H Comberg, M Yuen, RMF Agarwal, K Boonstra, A Ferret, MAB Piratvisuth, T Papatheodoridis, G Maasoumy, B CREATE study group,	2020
	Prediction Of Sustained Response After Nucleo(s)tide Analogue Cessation Using Hbsag And Hbcrag Levels – A Multicenter Study (create) Journal:Clinical Gastroenterology and Hepatology	Sonneveld, MJ Park, JY Kaewdech, A Seto, WK Tanaka, Y Carey, I Papatheodoridi, M van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GN Erler, NS Honer zu Siederdissen, C Wedemeyer, H Cornberg, M Yuen, MF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Maasoumy, B	2020
	Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels Journal:Journal of Hepatology	Sonneveld, MJ Chiu, SM Park, JY Brakenhoff, SM Kaewdech, A Seto, WKW Tanaka, Y Carey, I Papatheodoridi, M van Bommel, F Berg, T Zoulim, F Ahn, SH Dalekos, GS Erler, NS Honer zu Siederdissen, C Wedemeyer, H Cornberg, M Yuen, RMF Agarwal, K Boonstra, A Buti, M Piratvisuth, T Papatheodoridis, G Chen, CH Maasoumy, B	2022

Showing results 1 to 10 of 10